Home/Filings/4/0001367644-25-000058
4//SEC Filing

PAPA JOSEPH C 4

Accession 0001367644-25-000058

CIK 0001367644other

Filed

Mar 11, 8:00 PM ET

Accepted

Mar 12, 6:12 PM ET

Size

8.2 KB

Accession

0001367644-25-000058

Insider Transaction Report

Form 4
Period: 2025-03-12
PAPA JOSEPH C
DirectorPresident and CEO
Transactions
  • Award

    Employee Stock Options (Right to Buy)

    2025-03-12+250,0001,282,500 total
    Exercise: $2.33From: 2025-03-12Exp: 2031-03-12Common Stock (250,000 underlying)
  • Award

    Employee Stock Options (Right to Buy)

    2025-03-12+250,0001,532,500 total
    Exercise: $2.33From: 2025-03-12Exp: 2031-03-12Common Stock (250,000 underlying)
Footnotes (1)
  • [F1]Consists of an award of performance stock options granted under the company's Inducement Plan. These performance stock options vested in one annual installment on the day prior to the first anniversary of the date of grant based on the achievement of the $5 and $10 stock price performance hurdles as described in Mr. Papa's executive employment agreement dated February 19, 2024 (the "Papa Employment Agreement") and as certified by the company's Compensation Committee on February 12, 2025. Pursuant to the award, there remains 250,000 unvested performance stock options that are subject to a $15 stock price performance hurdle as described in the Papa Employment Agreement. Each performance stock option represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc. at the exercise price.

Issuer

Emergent BioSolutions Inc.

CIK 0001367644

Entity typeother

Related Parties

1
  • filerCIK 0001242215

Filing Metadata

Form type
4
Filed
Mar 11, 8:00 PM ET
Accepted
Mar 12, 6:12 PM ET
Size
8.2 KB